Detalhe da pesquisa
1.
Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation.
Nat Immunol
; 20(3): 288-300, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30692620
2.
Author Correction: Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation.
Nat Immunol
; 20(4): 514, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846879
3.
TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells.
Nat Immunol
; 15(7): 676-86, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24908389
4.
p21 Prevents the Exhaustion of CD4+ T Cells Within the Antitumor Immune Response Against Colorectal Cancer.
Gastroenterology
; 166(2): 284-297.e11, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734420
5.
IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling.
Gut
; 73(2): 282-297, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884352
6.
ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo.
Gut
; 73(4): 601-612, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38176897
7.
Biomarkers for Personalizing IBD Therapy: The Quest Continues.
Clin Gastroenterol Hepatol
; 2024 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320679
8.
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.
Gastroenterology
; 164(2): 241-255, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36279923
9.
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
Clin Gastroenterol Hepatol
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492903
10.
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Clin Gastroenterol Hepatol
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492904
11.
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials.
BMC Gastroenterol
; 24(1): 121, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539103
12.
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis.
Gut
; 72(1): 49-53, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428657
13.
Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation.
Gut
; 72(2): 275-294, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35241625
14.
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells.
Gut
; 72(11): 2081-2094, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541770
15.
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
Gastroenterology
; 163(4): 950-964, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788348
16.
Endocytoscopy for assessing histologic inflammation in ulcerative colitis: development and prospective validation of the ELECT (ErLangen Endocytoscopy in ColiTis) score (with videos).
Gastrointest Endosc
; 97(1): 100-111.e1, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058265
17.
Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing.
Int J Mol Sci
; 24(8)2023 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37108564
18.
Residual homing of α4ß7-expressing ß1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab.
Gut
; 71(8): 1551-1566, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462337
19.
Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis.
Gut
; 71(12): 2414-2429, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862250
20.
Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis.
Gastroenterology
; 161(4): 1270-1287.e19, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224738